FIGURE E.1 Survival plot of mice grafted with 5 × 106 Daudi cells followed by different intravenous treatments 2 days subsequent. From European Journal of Nuclear Medicine and Molecular Imaging 31(4), April 2004, G.-J. Beyer, M. Miederer, S. Vranješ-Đurić, J.J. Čomor, G. Künzi, O. Hartley, R. Senekowitsch-Schmidtke, D. Soloviev, F. Bechegger, and the ISOLDE Collaboration, “Targeted Alpha Therapy in Vivo: Direct Evidence for Single Cancer Cell Kill Using 149Tb-rituximab,” Figure 3, Copyright Springer-Verlag 2004 with kind permission of Springer Science and Business Media.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement